Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CytoPherx, Inc. logo — Pioneering medical advancements to combat inflammation-based...

CytoPherx, Inc.

Pioneering medical advancements to combat inflammation-based diseases with innovative selective cytopheresis systems.

Founded 2007 United States Ann Arbor, United States 2 employees Series C Total: $50.20M Health Care, Life Sciences +1

General Information

Company Name CytoPherx, Inc.
Founded Year 2007
Location United States Ann Arbor, United States
Employees 2
Industries Health Care, Life Sciences, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with CytoPherx, Inc.. To contact CytoPherx, Inc., visit cytopherx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About CytoPherx, Inc.

CytoPherx is a healthcare startup founded in 2007 and headquartered in the United States. The company is pioneering medical advancements to combat inflammation-based diseases with innovative selective cytopheresis systems. Formerly known as Nephrion, CytoPherx is a clinical-stage medical device company that focuses on diseases and conditions driven by inflammation. Their products are customized configurations of a proprietary system designed to modulate inflammation through selective cytopheresis. CytoPherx secured a significant $34.00M Series C investment on 04 January 2012, with contributions from a consortium of notable investors including Capital Midwest Fund, Early Stage Partners, Kaiser Permanente Ventures, Emergent Medical Partners, Onset Ventures, Aphelion Capital, Apjohn Ventures, Charter Oak Equity, North Coast Technology Investors, and the Lurie Investment Fund.

Taxonomy: medical device, clinical-stage, cytopheresis, inflammation, diseases, selective cytopheresis, medical advancement, innovation, inflammation-based diseases, inflammatory conditions, proprietary system, modulating inflammation, biomedical engineering

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $34.00M 10
Capital Midwest Fund Early Stage Partners Kaiser Permanente Ventures
Capital Midwest Fund, Early Stage Partners +8
04 Jan 2012
Series B $11.70M -
17 Jun 2010
Debt Financing $2.00M -
06 Nov 2009
Series A $2.50M -
22 Oct 2007

CytoPherx, Inc. Alternatives & Competitors

View All Alternatives
CytoPherx, Inc. vs
Immutrix Therapeutics
Immutrix Therapeutics

Pioneering advanced blood purification to combat inflammation and toxicity with innovative adsorbent...

Venture round
Biotechnology, Health Care
CytoPherx, Inc. vs
Third Harmonic Bio
Third Harmonic Bio United States

Advancing the next wave of medicine for inflammatory diseases

Series B
8 employees
Biotechnology, Health Care
CytoPherx, Inc. vs
Carthera
Carthera France

Advanced Brain Therapy

Series B
35 employees
Biotechnology, Health Care
View all alternatives

FAQ About CytoPherx, Inc.

Pioneering medical advancements to combat inflammation-based diseases with innovative selective cytopheresis systems.
CytoPherx, Inc. was founded in 2007.
CytoPherx, Inc. is headquartered in Ann Arbor, United States.
CytoPherx, Inc. operates in Health Care, Life Sciences and Medical Devices. Its work centres on medical device, clinical-stage, cytopheresis and inflammation.
CytoPherx, Inc. has approximately 2 employees.
CytoPherx, Inc. has completed 4 funding rounds, raising a total of $50.20M. The latest funding stage is Series C.
Top alternatives and competitors to CytoPherx, Inc. include Immutrix Therapeutics, Third Harmonic Bio, Carthera, Juventas Therapeutics, CenSyn, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CytoPherx, Inc. and Immutrix Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for CytoPherx, Inc., https://bouncewatch.com/company/cytopherx, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes